Jazz Pharmaceuticals plc ($JAZZ)
Filing Information
| Accession Number | 0001737329-26-000016 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 31, 2026 |
| Document | View SEC Filing |
Transactions
14
Total Shares
191,921
Total Value
$26,442,957.78
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Exercise/Conversion | 26,116 | $113.10 | $2,953,719.60 | 111,223 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Exercise/Conversion | 884 | $113.10 | $99,980.40 | 112,107 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Exercise/Conversion | 27,584 | $137.12 | $3,782,318.08 | 139,691 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Exercise/Conversion | 2,916 | $137.12 | $399,841.92 | 142,607 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Sale | 18,187 | $247.86 | $4,507,780.72 | 124,420 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Sale | 11,423 | $248.67 | $2,840,516.29 | 112,997 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Sale | 18,113 | $250.02 | $4,528,572.41 | 94,884 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Sale | 19,639 | $250.60 | $4,921,596.24 | 75,245 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Sale | 9,259 | $251.95 | $2,332,804.12 | 65,986 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Ordinary Shares | โ | Aug 27, 2026 | Sale | 300 | $252.76 | $75,828.00 | 65,686 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Incentive Stock Option (right to buy) | Derivative | Aug 27, 2026 | Exercise/Conversion | 884 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Incentive Stock Option (right to buy) | Derivative | Aug 27, 2026 | Exercise/Conversion | 2,916 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Non-Qualified Stock Option (right to buy) | Derivative | Aug 27, 2026 | Exercise/Conversion | 26,116 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, Global Head of R&D&CMO | Non-Qualified Stock Option (right to buy) | Derivative | Aug 27, 2026 | Exercise/Conversion | 27,584 | $0.00 | $0.00 | 0 | Direct | โ | View Details |